MHLW Approves AmoyDx® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek® (Entrectinib) in Japan
Date：0000-00-00Source: AmoyDx
Recommend
AmoyDx® Master Panel--Study Reveals Clinically Relevant Intertumoral Heterogeneity of NSCLCs Driven by MET Exon 14 Skipping Mutation
17 /08
Amoy Diagnostics and Roche Pharma China Jointly Announce Strategic Partnership
17 /08
MHLW Approves AmoyDx® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek® (Entrectinib) in Japan
09 /08
Visit AmoyDx at IASLC 2022 World Conference on Lung Cancer in Vienna, Austria from August 6 – 9,
08 /07
Visit AmoyDx at 2022 ASCO Annual Meeting in Chicago, IL, USA
05 /05